Alyeska Investment Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-50,982
| Closed | -$5.2M | – | 642 |
|
|
2023
Q2 | $5.2M | Buy |
+50,982
| New | +$5.2M | 0.04% | 319 |
|
|
2018
Q2 | – | Sell |
-152,323
| Closed | -$3.12M | – | 514 |
|
|
2018
Q1 | $3.12M | Sell |
152,323
-53,252
| -26% | -$1.09M | 0.03% | 296 |
|
|
2017
Q4 | $5.82M | Buy |
205,575
+114,527
| +126% | +$3.24M | 0.05% | 234 |
|
|
2017
Q3 | $2.83M | Buy |
+91,048
| New | +$2.83M | 0.02% | 308 |
|